HIF1A and cancer: Hypoxia inducible factor-1 (HIF-1) is a transcriptional regulator responded to hypoxia to modulate glycolytic enzymes 6, 7, that is considered as a poor prognostic factor of cancer and is a malignant contributor of metabolic alteration, angiogenesis, invasiveness, therapeutic resistance, immune escape, and resistance to cell death 8.